{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:32:23Z","timestamp":1793061143252,"version":"4.5.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00228-026-04209-1","type":"journal-article","created":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:28:26Z","timestamp":1792808906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Body mass index and psychotropic drug concentrations in eating disorders: methodological considerations and clinical implications"],"prefix":"10.1007","volume":"82","author":[{"given":"Priyanka","family":"Ochani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushman","family":"Ochani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konain","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubaisha","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,24]]},"reference":[{"key":"4209_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00228-026-04175-8","volume":"82","author":"V Hersleth","year":"2026","unstructured":"Hersleth V, Spigset O, Weider S, Koch E, Andreassen OA, Lydersen S, Fjukstad KK (2026) Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders. Eur J Clin Pharmacol 82:249","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"4209_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/FTD.0b013e318237b0fa","volume":"33","author":"S Unterecker","year":"2011","unstructured":"Unterecker S, Deckert J, Pfuhlmann B (2011) No influence of body weight on serum levels of antidepressants. Ther Drug Monit 33(6):730\u2013734","journal-title":"Ther Drug Monit"},{"issue":"6","key":"4209_CR3","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/FTD.0000000000001227","volume":"46","author":"N Ansermot","year":"2024","unstructured":"Ansermot N, Vathanarasa H, Ranjbar S, Gholam M, Crettol S, Vandenberghe F et al (2024) Therapeutic drug monitoring of olanzapine: Effects of clinical factors on plasma concentrations in psychiatric patients. Ther Drug Monit 46(6):828\u2013836","journal-title":"Ther Drug Monit"},{"issue":"3","key":"4209_CR4","doi-asserted-by":"publisher","first-page":"e00615","DOI":"10.1002\/prp2.615","volume":"8","author":"P Sandvik","year":"2020","unstructured":"Sandvik P, Lydersen S, Hegstad S, Spigset O (2020) Association between low body weight and cytochrome P-450 enzyme activity in patients with anorexia nervosa. Pharmacol Res Perspect 8(3):e00615","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"4209_CR5","doi-asserted-by":"publisher","first-page":"e004216","DOI":"10.1136\/bmjopen-2013-004216","volume":"4","author":"Y Tsuda","year":"2014","unstructured":"Tsuda Y, Saruwatari J, Yasui-Furukori N (2014) Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine. BMJ Open 4(3):e004216","journal-title":"BMJ Open"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04209-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:41:07Z","timestamp":1793058067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04209-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,24]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4209"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04209-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,24]]},"assertion":[{"value":"11 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"279"}}